EE556 Inpatient Cost of Managing Adverse Events (AEs) Associated With Immune Checkpoint Inhibitors (ICI) Approved for Advanced or Metastatic Cancers in the UK
Abstract
Authors
Jyotika Gandhi Sandip Ranjan Anindya Mukherjee Susmit Sambhare Rizwan Ameen Ravi Potluri